文献速递真菌感染艾滋病与性传播感染

非洲晚期HIV病患者侵袭性真菌感染的诊断能力:一项全洲调查

Diagnostic capacity for invasive fungal infections in advanced HIV disease in Africa: a continent-wide survey.
PubMed 文献 · Lancet Infect Dis · 2022-12-21

该全洲调查覆盖非洲48个国家、99.65%的非洲人口,于2020年10月1日至2022年10月31日收集数据,评估晚期HIV病患者侵袭性真菌感染的诊断可及性。调查强调非洲HIV相关真菌感染诊断面临巨大挑战,亟需政治和全球卫生领导层改善诊断。

核心结论

  • 调查突显非洲在诊断HIV相关肺孢子菌肺炎、隐球菌病、组织胞浆菌病和其他真菌感染方面面临巨大挑战。
  • 紧急的政治和全球卫生领导层可改善非洲真菌感染诊断,减少可避免的死亡。

研究设计与样本

  • 调查覆盖99.65%的非洲人口,数据收集时间为2020年10月1日至2022年10月31日。
  • 调查分六阶段:问卷开发与改进、国内受访者填写、问卷审核与数据分析及视频会议、公共或私人来源外部验证、与卫生部高级官员视频会议国家验证、非洲疾病预防控制中心领导的五场区域网络研讨会。

关键数值与推荐

  • 在40个非洲国家分析中,抗逆转录病毒治疗使用与外源性HIV关怀支出呈中度相关(R²=0.42),外源性支出与艾滋病死亡率几乎无相关(R²=0.18)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Fungal infections are common causes of death and morbidity in those with advanced HIV infection. Data on access to diagnostic tests in Africa are scarce. We aimed to evaluate the diagnostic capacity for invasive fungal infections in advanced HIV disease in Africa. METHODS: We did a continent-wide survey by collecting data from 48 of 49 target countries across Africa with a population of more than 1 million; for Lesotho, only information on the provision of cryptococcal antigen testing was obtained. This survey covered 99·65% of the African population. We did the survey in six stages: first, questionnaire development, adaptation, and improvement; second, questionnaire completion by in-country respondents; third, questionnaire review and data analysis followed by video conference calls with respondents; fourth, external validation from public or private sources; fifth, country validation by video conference with senior figures in the Ministry of Health; and sixth, through five regional webinars led by the Africa Centres for Disease Control and Prevention with individual country profiles exchanged by email. Data was compiled and visualised using the Quantum Geographic Information System software and Natural Earth vectors to design maps showing access. FINDINGS: Data were collected between Oct 1, 2020, and Oct 31, 2022 in the 48 target countries. We found that cryptococcal antigen testing is frequently accessible to 358·39 million (25·5%) people in 14 African countries. Over 1031·49 million (73·3%) of 1·4 billion African people have access to a lumbar puncture. India ink microscopy is frequently accessible to 471·03 million (33·5%) people in 23 African countries. About 1041·62 million (74·0%) and 1105·11 million (78·5%) people in Africa do not have access to histoplasmosis and Pneumocystis pneumonia diagnostics in either private or public facilities, respectively. Fungal culture is available in 41 countries covering a population of 1·289 billion (94%) people in Africa. MRI is routinely accessible to 453·59 million (32·2%) people in Africa and occasionally to 390·58 million (27·8%) people. There was a moderate correlation between antiretroviral therapy usage and external expenditure on HIV care (R2=0·42) but almost none between external expenditure and AIDS death rate (R2=0·18), when analysed for 40 African countries. INTERPRETATION: This survey highlights the enormous challenges in the diagnosis of HIV-associated Pneumocystis pneumonia, cryptococcal disease, histoplasmosis, and other fungal infections in Africa. Urgent political and global health leadership could improve the diagnosis of fungal infections in Africa, reducing avoidable deaths. FUNDING: Global Action For Fungal Infections.

来源:Lancet Infect Dis,查看原文。版权归原作者所有。

引用

  1. Lakoh S, Kamudumuli PS, Penney ROS, et al. Diagnostic capacity for invasive fungal infections in advanced HIV disease in Africa: a continent-wide survey. Lancet Infect Dis. 2022. PMID: 36565714. doi:10.1016/S1473-3099(22)00656-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。